Works matching DE "BUPRENORPHINE"

Results: 3163

Error in Abstract.

Published in:: 2025
Publication type:: Correction Notice

Extended-release Injectable Buprenorphine Initiation in the Emergency Department.

Published in:

Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health, 2025, v. 26, n. 4, p. 888, doi. 10.5811/westjem.21299

By:

Cesar, Brittany;
Moore, Jessica;
Isenberg, Raluca;
Heil, Jessica;
Rafeq, Rachel;
Haroz, Rachel;
Salzman, Matthew;
Ely, Alice V.

Publication type:

Article

Expanding Horizons of Buprenorphine: A Comprehensive Narrative Review of Its Pharmacological Properties and Clinical Applications in Chronic Pain.

Published in:

Pain & Therapy, 2025, v. 14, n. 4, p. 1247, doi. 10.1007/s40122-025-00753-3

By:

Fornasari, Diego;
Cuomo, Arturo

Publication type:

Article

The Mainstreaming Addiction Treatment Act and Pharmacist-Prescribed Buprenorphine.

Published in:

JAMA: Journal of the American Medical Association, 2025, v. 334, n. 3, p. 269, doi. 10.1001/jama.2025.7151

By:

Tran, Emmy L.;
Rikard, S. Michaela;
Guy Jr, Gery P.;
Mikosz, Christina A.

Publication type:

Article

Racial and Ethnic Factors and Opioid Use Disorder Treatment After an Emergency Department Visit.

Published in:

JAMA Network Open, 2025, v. 8, n. 7, p. e2520661, doi. 10.1001/jamanetworkopen.2025.20661

By:

Coupet Jr, Edouard;
Chawarski, Marek C.;
Hercules, Kavari;
Williams, Joseph L.;
Murphy Ward, Alexandra;
Owens, Patricia H.;
Fiellin, David A.;
Hawk, Kathryn F.;
Martel, Shara H.;
D'Onofrio, Gail

Publication type:

Article

Use of Buprenorphine/Naloxone in an Adult with Cystic Fibrosis.

Published in:

Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière, 2025, v. 78, n. 2, p. 1, doi. 10.4212/cjhp.3700

By:

Mihic, Tamara;
Fairbairn, Nadia;
Nolan, Seonaid;
Dagenais, Renée;
Quon, Bradley S.;
Socias, M. Eugenia

Publication type:

Article

Buprenorphine Versus Methadone in Female New Zealand White Rabbits Undergoing Balanced Anaesthesia for Calvaria Surgery.

Published in:

Animals (2076-2615), 2025, v. 15, n. 13, p. 1843, doi. 10.3390/ani15131843

By:

Casoni, Daniela;
Parodi, Chiara;
Garcia Casalta, Luisana Gisela;
Nettelbeck, Kay;
Spadavecchia, Claudia

Publication type:

Article

Comparison between Bupivacaine alone and bupivacaine plus buprenorphine using ultrasound guided supraclavicular block at a tertiary care hospital.

Published in:

Professional Medical Journal, 2025, v. 32, n. 7, p. 803, doi. 10.29309/TPMJ/2025.32.07.9807

By:

Aftab, Iqra;
Gulzar, Javaria;
Butt, Sadiya;
Akbar, Mafia;
Riaz, Mariam;
Malik, Ayesha

Publication type:

Article

Buprenorphine Extended-Release Injection for Subcutaneous Use (Sublocade<sup>®</sup>): An Overview for Psychiatric Advanced Practice Nurses.

Published in:

Journal of Psychosocial Nursing & Mental Health Services, 2025, v. 63, n. 7, p. 7, doi. 10.3928/02793695-20250612-03

By:

Kameg, Brayden

Publication type:

Article

Evaluation of Immunoassay Performance for the Detection of Opioids in Urine.

Published in:

Journal of Applied Laboratory Medicine, 2025, v. 10, n. 3, p. 559, doi. 10.1093/jalm/jfae169

By:

Walsh, Michael E.;
Kelliher, Michael T.;
Hubbard, Jacqueline A.;
Cervinski, Mark A.

Publication type:

Article

Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients.

Published in:

JAMA Network Open, 2025, v. 8, n. 7, p. e2518569, doi. 10.1001/jamanetworkopen.2025.18569

By:

Shastry, Siri;
Carpenter, Joseph;
Krotulski, Alex;
Brent, Jeffrey;
Wax, Paul;
Aldy, Kim;
Campleman, Sharan;
Culbreth, Rachel;
Falise, Alyssa;
Hughes, Adrienne;
Hendrickson, Robert G.;
Amaducci, Alexandra;
Judge, Bryan;
Meaden, Christopher;
Calello, Diane P.;
Buchanan, Jennie;
Shulman, Joshua;
Levine, Michael;
Schwarz, Evan;
Manini, Alex F.

Publication type:

Article

Duration of Methadone and Buprenorphine-Naloxone Treatment.

Published in:

JAMA Network Open, 2025, v. 8, n. 7, p. e2518389, doi. 10.1001/jamanetworkopen.2025.18389

By:

Kleinman, Robert A.;
Kurdyak, Paul

Publication type:

Article

Retention in Opioid Agonist Therapy Among First Nations People.

Published in:

JAMA Network Open, 2025, v. 8, n. 6, p. e2518452, doi. 10.1001/jamanetworkopen.2025.18452

By:

Holton, Alice;
Hamzat, Bisola;
McCormack, Daniel;
Bragg, Sacha;
deGonzague, Bernadette;
Mecredy, Graham;
Campbell, Tonya;
Antoniou, Tony;
McGregor, Lorrilee;
Bertram, Jonathan;
Gomes, Tara

Publication type:

Article

Ketamine treatment for buprenorphine-precipitated opioid withdrawal: a case report.

Published in:

Frontiers in Psychiatry, 2025, p. 1, doi. 10.3389/fpsyt.2025.1586945

By:

Gbujie, Ezioma;
Vercollone, Lisa;
Suzuki, Joji

Publication type:

Article

Comparative effectiveness of extended‐release naltrexone versus buprenorphine‐naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population‐based observational data

Published in:

Addiction, 2025, v. 120, n. 8, p. 1634, doi. 10.1111/add.70040

By:

Lodi, Sara;
Yan, Shapei;
Bovell‐Ammon, Benjamin;
Christine, Paul J.;
Hsu, Heather E.;
Bernson, Dana;
Novo, Patricia;
Lee, Joshua D.;
Rotrosen, John;
Liebschutz, Jane M.;
Walley, Alexander Y.;
Larochelle, Marc R.

Publication type:

Article

Medication experiences in the treatment of opioid use disorders: Insights from Reddit.

Published in:

Addiction, 2025, v. 120, n. 8, p. 1610, doi. 10.1111/add.70022

By:

Almeida, Alexandra;
Conway, Mike;
Grelotti, David J.;
Gupta, Amarnath;
Frank, David;
Bórquez, Annick

Publication type:

Article

Treating Opioid Use Disorder on the Inpatient Psychiatric Unit: A Novel Buprenorphine Consultation Service.

Published in:

Pharmacoepidemiology (2813-0618), 2025, v. 4, n. 2, p. 11, doi. 10.3390/pharma4020011

By:

Lynch, Sean T.;
Gordillo, Victor;
Sacks, Ashley;
Groenendaal, Emily;
Klepacz, Lidia;
Towey, Eldene;
Ferrando, Stephen J.

Publication type:

Article

Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder by Race and Ethnicity and Insurance Type.

Published in:

JAMA Network Open, 2025, v. 8, n. 6, p. e2518493, doi. 10.1001/jamanetworkopen.2025.18493

By:

Khatri, Utsha G.;
Lopez, Christopher;
Yen, Yun-Ting;
Ling, Emilia J.;
Richardson, Lynne D.;
Ngai, Ka Ming

Publication type:

Article

Availability of Medications for Opioid Use Disorder in Opioid Treatment Programs.

Published in:

JAMA Network Open, 2025, v. 8, n. 6, p. e2517616, doi. 10.1001/jamanetworkopen.2025.17616

By:

Lindenfeld, Zoe;
Cantor, Jonathan H.;
Mauri, Amanda I.;
Bandara, Sachini;
Suryavanshi, Aarya;
Krawczyk, Noa

Publication type:

Article

Ongoing Gaps in Buprenorphine Treatment—Urgency and Opportunity.

Published in:

2025

By:

Wakeman, Sarah E.

Publication type:

Opinion

Review article: Rapid review of the emergency department‐initiated buprenorphine for opioid use disorder.

Published in:

Emergency Medicine Australasia, 2020, v. 32, n. 6, p. 924, doi. 10.1111/1742-6723.13654

By:

Salter, Helen;
Hutton, Jennie;
Cantwell, Kate;
Dietze, Paul;
Higgs, Peter;
Straub, Adam;
Zordan, Rachel;
Lloyd‐Jones, Martyn

Publication type:

Article

Interpersonal Trauma Among Women and Men Receiving Buprenorphine in Outpatient Treatment for Opioid Use Disorder.

Published in:

Violence Against Women, 2022, v. 28, n. 10, p. 2448, doi. 10.1177/10778012211032715

By:

Martin, Caitlin E.;
Parlier-Ahmad, Anna Beth;
Beck, Lori;
Thomson, Nicholas D.

Publication type:

Article

A Comparison of Pregnancy-Only versus Mixed-Gender Group Therapy among Pregnant Women with Opioid Use Disorder.

Published in:

Social Work Research, 2015, v. 39, n. 4, p. 235, doi. 10.1093/swr/svv029

By:

Lander, Laura R.;
Gurka, Kelly K.;
Marshalek, Patrick J.;
Riffon, Mark;
Sullivan, Carl R.

Publication type:

Article

Overcoming Barriers: Individual Experiences Obtaining Medication-Assisted Treatment for Opioid Use Disorder.

Published in:

Qualitative Health Research, 2020, v. 30, n. 13, p. 2103, doi. 10.1177/1049732320938689

By:

Scorsone, Krista L.;
Haozous, Emily A.;
Hayes, Leslie;
Cox, Kim J.

Publication type:

Article

Magnetocardiographic identification of prolonged fetal corrected QT interval in women receiving treatment for opioid use disorder.

Published in:

Journal of Obstetrics & Gynaecology Research, 2019, v. 45, n. 10, p. 1989, doi. 10.1111/jog.14055

By:

Bolin, Elijah H.;
Escalona‐Vargas, Diana;
Daily, Joshua A.;
Siegel, Eric R.;
Lowery, Curtis L.;
Coker, Jessica;
Stowe, Zachary N.;
Eswaran, Hari

Publication type:

Article

Treatment discontinuation less likely with methadone than buprenorphine/naloxone.

Published in:: Brown University Psychopharmacology Update, 2025, v. 36, n. 2, p. 7, doi. 10.1002/pu.31267
Publication type:: Article

Higher‐dose buprenorphine linked to reduced health care utilization.

Published in:: Brown University Psychopharmacology Update, 2025, v. 36, n. 2, p. 7, doi. 10.1002/pu.31266
Publication type:: Article

Buprenorphine‐naloxone combination appears safe during pregnancy.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 12, p. 3, doi. 10.1002/pu.31238
Publication type:: Article

Seven‐day buprenorphine feasible in patients with minimal to mild opioid withdrawal.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 11, p. 3, doi. 10.1002/pu.31226
Publication type:: Article

Higher dose of buprenorphine improved retention in treatment.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 2, p. 8, doi. 10.1002/pu.31126
Publication type:: Article

Gabapentin does not increase poisoning risk in buprenorphine patients.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 12, p. 7, doi. 10.1002/pu.31100
Publication type:: Article

Meta‐analysis shows small benefit from buprenorphine in depression.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 9, p. 6, doi. 10.1002/pu.31063
Publication type:: Article

Black patients with OUD less likely to receive medication treatments.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 9, p. 4, doi. 10.1002/pu.31061
Publication type:: Article

Disruption in medication for OUD exacerbates risk of overdose.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 7, p. 8, doi. 10.1002/pu.31039
Publication type:: Article

Buprenorphine shows lower risk of adverse neonatal outcomes than methadone.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 3, doi. 10.1002/pu.30996
Publication type:: Article

Gaps in buprenorphine treatment exacerbate risk of overdose.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 2, p. 7, doi. 10.1002/pu.30977
Publication type:: Article

Expanded access to OUD medication during pandemic proved beneficial.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 1, p. 6, doi. 10.1002/pu.30964
Publication type:: Article

Take‐home dosing of buprenorphine/naloxone noninferior to methadone in OUD treatment.

Published in:: Brown University Psychopharmacology Update, 2022, v. 33, n. 10, p. 3, doi. 10.1002/pu.30926
Publication type:: Article

OUD patients with polysubstance use less likely to initiate buprenorphine.

Published in:: Brown University Psychopharmacology Update, 2022, v. 33, n. 9, p. 8, doi. 10.1002/pu.30920
Publication type:: Article

Medication for opioid use disorder reduced suicide risk among veterans.

Published in:: Brown University Psychopharmacology Update, 2022, v. 33, n. 7, p. 1, doi. 10.1002/pu.30888
Publication type:: Article

Self‐harm risk decreases with extended opioid agonist treatment.

Published in:: Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 7, doi. 10.1002/pu.30857
Publication type:: Article

High‐dose buprenorphine induction in emergency care appears safe.

Published in:: Brown University Psychopharmacology Update, 2021, v. 32, n. 11, p. 8, doi. 10.1002/pu.30797
Publication type:: Article

Injectable buprenorphine formulations lead to greater patient satisfaction.

Published in:: Brown University Psychopharmacology Update, 2021, v. 32, n. 10, p. 8, doi. 10.1002/pu.30787
Publication type:: Article

The end of the buprenorphine waiver.

Published in:: Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 7, doi. 10.1002/pu.30773
Publication type:: Article

New buprenorphine guidelines exempt some providers from training mandate.

Published in:: Brown University Psychopharmacology Update, 2021, v. 32, n. 8, p. 8, doi. 10.1002/pu.30761
Publication type:: Article

Poisoning risk in buprenorphine patients increases with benzodiazepine use.

Published in:: Brown University Psychopharmacology Update, 2021, v. 32, n. 6, p. 7, doi. 10.1002/pu.30731
Publication type:: Article

Monthly buprenorphine injection for opioid use disorder appears safe.

Published in:: Brown University Psychopharmacology Update, 2020, v. 31, n. 8, p. 8, doi. 10.1002/pu.30611
Publication type:: Article

Comparative study shows superiority of medications for opioid use disorder.

Published in:: Brown University Psychopharmacology Update, 2020, v. 31, n. 6, p. 4, doi. 10.1002/pu.30582
Publication type:: Article

Use of buprenorphine lags compared to patient need.

Published in:: Brown University Psychopharmacology Update, 2020, v. 31, n. 5, p. 8, doi. 10.1002/pu.30574
Publication type:: Article

Cohort study demonstrates protective effect of long‐term treatment with buprenorphine.

Published in:: Brown University Psychopharmacology Update, 2020, v. 31, n. 4, p. 3, doi. 10.1002/pu.30554
Publication type:: Article